201 related articles for article (PubMed ID: 9660801)
1. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.
Schedlich LJ; Young TF; Firth SM; Baxter RC
J Biol Chem; 1998 Jul; 273(29):18347-52. PubMed ID: 9660801
[TBL] [Abstract][Full Text] [Related]
2. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit.
Schedlich LJ; Le Page SL; Firth SM; Briggs LJ; Jans DA; Baxter RC
J Biol Chem; 2000 Aug; 275(31):23462-70. PubMed ID: 10811646
[TBL] [Abstract][Full Text] [Related]
3. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
4. A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import.
Iosef C; Gkourasas T; Jia CY; Li SS; Han VK
Endocrinology; 2008 Mar; 149(3):1214-26. PubMed ID: 18039785
[TBL] [Abstract][Full Text] [Related]
5. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization.
Lee KW; Liu B; Ma L; Li H; Bang P; Koeffler HP; Cohen P
J Biol Chem; 2004 Jan; 279(1):469-76. PubMed ID: 14576164
[TBL] [Abstract][Full Text] [Related]
6. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
[TBL] [Abstract][Full Text] [Related]
7. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid.
Shemer J; Yaron A; Werner H; Shao ZM; Sheikh MS; Fontana JA; LeRoith D; Roberts CT
J Clin Endocrinol Metab; 1993 Nov; 77(5):1246-50. PubMed ID: 7521344
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-3 increases intracellular calcium concentrations in MCF-7 breast carcinoma cells.
Ricort JM; Lombet A; Lassarre C; Binoux M
FEBS Lett; 2002 Sep; 527(1-3):293-7. PubMed ID: 12220677
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-3 is secreted as a phosphoprotein by human breast cancer cells.
Pattison ST; Fanayan S; Martin JL
Mol Cell Endocrinol; 1999 Oct; 156(1-2):131-9. PubMed ID: 10612431
[TBL] [Abstract][Full Text] [Related]
10. Importin α-importin β complex mediated nuclear translocation of insulin-like growth factor binding protein-5.
Sun M; Long J; Yi Y; Xia W
Endocr J; 2017 Oct; 64(10):963-975. PubMed ID: 28835592
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).
Amaar YG; Thompson GR; Linkhart TA; Chen ST; Baylink DJ; Mohan S
J Biol Chem; 2002 Apr; 277(14):12053-60. PubMed ID: 11821401
[TBL] [Abstract][Full Text] [Related]
12. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
14. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
Hong J; Zhang G; Dong F; Rechler MM
J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3.
Oufattole M; Lin SW; Liu B; Mascarenhas D; Cohen P; Rodgers BD
Endocrinology; 2006 May; 147(5):2138-46. PubMed ID: 16455777
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of IGFBP-mediated endocytosis in the human retinal pigment epithelial cell line ARPE-19.
Ainscough SL; Feigl B; Malda J; Harkin DG
Exp Eye Res; 2009 Nov; 89(5):629-37. PubMed ID: 19540231
[TBL] [Abstract][Full Text] [Related]
18. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.
Butt AJ; Fraley KA; Firth SM; Baxter RC
Endocrinology; 2002 Jul; 143(7):2693-9. PubMed ID: 12072403
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.
Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B
Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells.
Micutkova L; Hermann M; Offterdinger M; Hess MW; Matscheski A; Pircher H; Mück C; Ebner HL; Laich A; Ferrando-May E; Zwerschke W; Huber LA; Jansen-Dürr P
Int J Cancer; 2012 Apr; 130(7):1544-57. PubMed ID: 21520041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
